Kanda Y - Search Results

1

Impact of standard-dose dipeptidyl peptidase-4 inhibitors on the incidence of graft-versus-host disease after allogeneic hematopoietic cell transplantation.

Kimura SI, Shimizu H, Miyazaki T, Sakurai M, Tanoue S, Kayamori K, Ohwada C, Yoshimura K, Nakasone H, Ohashi T, Shono K, Tachibana T, Hatano K, Okada K, Kimura Y, Seo S, Doki N, Tanaka M, Hatta Y, Takahashi S, Kanda Y; Kanto Study Group for Cell Therapy. Kimura SI, et al. Among authors: kanda y. Bone Marrow Transplant. 2023 Apr;58(4):452-455. doi: 10.1038/s41409-022-01901-5. Epub 2022 Dec 26. Bone Marrow Transplant. 2023. PMID: 36572728 No abstract available.

2

Graft-versus-tumor effect against advanced pancreatic cancer after allogeneic reduced-intensity stem cell transplantation.

Kanda Y, Komatsu Y, Akahane M, Kojima S, Asano-Mori Y, Tada M, Oshima K, Isayama H, Ogawa S, Motokura T, Chiba S, Ohtomo K, Omata M, Hirai H. Kanda Y, et al. Transplantation. 2005 Apr 15;79(7):821-7. doi: 10.1097/01.tp.0000153507.94980.a5. Transplantation. 2005. PMID: 15818325 Clinical Trial.

3

Effect of conditioning regimen on the outcome of bone marrow transplantation from an unrelated donor.

Kanda Y, Sakamaki H, Sao H, Okamoto S, Kodera Y, Tanosaki R, Kasai M, Hiraoka A, Takahashi S, Miyawaki S, Kawase T, Morishima Y, Kato S; Japan Marrow Donor Program. Kanda Y, et al. Biol Blood Marrow Transplant. 2005 Nov;11(11):881-9. doi: 10.1016/j.bbmt.2005.07.005. Biol Blood Marrow Transplant. 2005. PMID: 16275591 Free article.

4

Decreased incidence of acute graft-versus-host disease by continuous infusion of cyclosporine with a higher target blood level.

Oshima K, Kanda Y, Nakasone H, Arai S, Nishimoto N, Sato H, Watanabe T, Hosoya N, Izutsu K, Asai T, Hangaishi A, Motokura T, Chiba S, Kurokawa M. Oshima K, et al. Among authors: kanda y. Am J Hematol. 2008 Mar;83(3):226-32. doi: 10.1002/ajh.21087. Am J Hematol. 2008. PMID: 17918253 Free article.

5

False-positive Aspergillus galactomannan antigenaemia after haematopoietic stem cell transplantation.

Asano-Mori Y, Kanda Y, Oshima K, Kako S, Shinohara A, Nakasone H, Kaneko M, Sato H, Watanabe T, Hosoya N, Izutsu K, Asai T, Hangaishi A, Motokura T, Chiba S, Kurokawa M. Asano-Mori Y, et al. Among authors: kanda y. J Antimicrob Chemother. 2008 Feb;61(2):411-6. doi: 10.1093/jac/dkm463. Epub 2007 Nov 30. J Antimicrob Chemother. 2008. PMID: 18055488

6

Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.

Asano-Mori Y, Kanda Y, Oshima K, Kako S, Shinohara A, Nakasone H, Sato H, Watanabe T, Hosoya N, Izutsu K, Asai T, Hangaishi A, Motokura T, Chiba S, Kurokawa M. Asano-Mori Y, et al. Among authors: kanda y. Am J Hematol. 2008 Jun;83(6):472-6. doi: 10.1002/ajh.21152. Am J Hematol. 2008. PMID: 18266207 Free article.

7

Clinical features of late cytomegalovirus infection after hematopoietic stem cell transplantation.

Asano-Mori Y, Kanda Y, Oshima K, Kako S, Shinohara A, Nakasone H, Sato H, Watanabe T, Hosoya N, Izutsu K, Asai T, Hangaishi A, Motokura T, Chiba S, Kurokawa M. Asano-Mori Y, et al. Among authors: kanda y. Int J Hematol. 2008 Apr;87(3):310-8. doi: 10.1007/s12185-008-0051-1. Epub 2008 Mar 5. Int J Hematol. 2008. PMID: 18320138

8

Central nervous system relapse of leukemia after allogeneic hematopoietic stem cell transplantation.

Oshima K, Kanda Y, Yamashita T, Takahashi S, Mori T, Nakaseko C, Fujimaki K, Yokota A, Fujisawa S, Matsushima T, Fujita H, Sakura T, Okamoto S, Maruta A, Sakamaki H; Kanto Study Group for Cell Therapy. Oshima K, et al. Among authors: kanda y. Biol Blood Marrow Transplant. 2008 Oct;14(10):1100-1107. doi: 10.1016/j.bbmt.2008.07.002. Biol Blood Marrow Transplant. 2008. PMID: 18804039 Free article.

9

Fludarabine, cyclophosphamide, anti-thymocyteglobulin, and low-dose total body irradiation conditioning enables 1-HLA-locus-mismatched hematopoietic stem cell transplantation for very severe aplastic anemia without affecting ovarian function.

Okuda S, Terasako K, Oshima K, Sato M, Nakasone H, Kako S, Yamazaki R, Tanaka Y, Tanihara A, Higuchi T, Nishida J, Kanda Y. Okuda S, et al. Among authors: kanda y. Am J Hematol. 2009 Mar;84(3):167-9. doi: 10.1002/ajh.21355. Am J Hematol. 2009. PMID: 19195036 Free article.

10

Reverse seroconversion of hepatitis B virus after allogeneic hematopoietic stem cell transplantation in the absence of chronic graft-versus-host disease.

Oshima K, Sato M, Okuda S, Terasako K, Nakasone H, Kako S, Yamazaki R, Tanaka Y, Tanihara A, Higuchi T, Nishida J, Nakamura I, Yoshida Y, Kanda Y. Oshima K, et al. Among authors: kanda y. Hematology. 2009 Apr;14(2):73-5. doi: 10.1179/102453309X385223. Hematology. 2009. PMID: 19298717

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,359 results

Search Page